this is an outdated text: switch to the updated & improved dc code website
home, about

The DC Code: § 28-4553 Excessive pricing in sales of prescription drugs, a violation of law.

Index28 Commercial Instruments and Transactions. (Refs & Annos)

It shall be unlawful for any drug manufacturer or licensee thereof, excluding a point of sale retail seller, to sell or supply for sale or impose minimum resale requirements for a patented prescription drug that results in the prescription drug being sold in the District for an excessive price.

Historical and Statutory

Legislative History of Laws For Law 16-37, see notes following § 28-4551. DC CODE § 28-4553 Current through December 11, 2012

Credits

(Dec. 10, 2005, D.C. Law 16-37, § 2, 52 DCR 9061.) GENERAL NOTES This chapter has been held unconstitutional in the case of Pharmaceutical Research and Mfrs. of America v. District of Columbia, 2005, 406 F.Supp.2d 56, 78 U.S.P.Q.2d 1822, affirmed 496 F.3d 1362, 83 U.S.P.Q.2d 1639, rehearing and rehearing en banc denied 505 F.3d 1343, 85 U.S.P.Q.2d 1144.